Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
用户ZHpUxjhiFwbk
1个月前
61
10
已完结
1. 系统已在2025-12-03 10:57:44对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s40262-025-01499-z
文献链接: https://link.springer.com/10.1007/s40262-025-01499-z
其他信息:
出版社: Springer Science and Business Media LLC
作者: Stephanie Kong; Mukul Minocha; Po-Wei Chen; Pablo Martinez; Erik S. Anderson; Amanda Parkes; Brett E. Houk; Chih-Wei Lin
全文下载地址: https://link.springer.com/content/pdf/10.1007/s40262-025-01499-z.pdf
